SANGAMO BIOSCIENCES (NASDAQ:SGMO)
5.51
+0.04 (0.73%)
| SANGAMO BIOSCIENCES (NASDAQ:SGMO) Delayed : |
| Previous Close |
$5.47 |
|
52 Week High |
$9.39 |
|
| Open |
$5.39 |
|
52 Week Low |
$1.82 |
| Day High |
$5.67 |
|
P/E |
N/A |
| Day Low |
$5.31 |
|
EPS |
$-0.47 |
| Volume |
170,708 |
|
|
|
| More SGMO Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on SGMO
-
Nov 4, 2009 05:49 PM
Sangamo (SGMO) Reports Q3 Loss of $0.12, Beats by 1c
-
Nov 3, 2009 01:42 PM
Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
-
Oct 20, 2009 02:09 PM
Sangamo (SGMO) to Present Top-Line, Statistically Significant Phase 2 Data from ZFP Therapeutic(TM) Program
-
Oct 19, 2009 09:21 AM
Brean Murray Initiates Coverage on Sangamo BioSciences (SGMO) with a Sell; Negative Clinical Data
-
Oct 7, 2009 01:37 PM
Unusual 11 Mid-Day Movers 10/07: RPRX, TWMC, DDSS, TLR Higher; MERX, AAI, SASR, SGMO Lower
View All Reports
StreetInsider Reports on SGMO by Category
-
Oct 26, 2009 03:15 AM
19 'Babies with Bathwater' and 1 'Dog with Fleas' Stocks for the Week
-
Oct 18, 2009 09:03 AM
Biotech Companies Turn to Capital Markets
-
Oct 14, 2009 05:45 AM
2 'Babies with Bathwater' and 20 'Dogs with Fleas' Stocks for the Week
-
Oct 2, 2009 11:40 AM
Sangamo (SGMO): Progress in adult stem calls?
-
Feb 5, 2009 07:51 AM
Top Pre-Market Analyst Upgrades (AEZS, AKAM, CNQR, HK, SJT, SGMO, THRX)
View All Blogs
Comments on recent SGMO articles
Comments on SGMO
No comments are currently available.
on Jul 2, 2009
at 06:21 PM sucessful ZFN knockpout of 2 CHO genes So are we to assume that Genentech is targeting OVARIAN CANCER? They succesfully knocked out those genes to stop the cancer?
Article: Sangamo BioSciences (SGMO) Announced Key Milestone Reached in Cell Engineering Agreement With Genentech